McCormick, Nike jump premarket; Phreesia sinks By Investing.com

By 06:32 ET futures were up: Dow futures +373 points (+0.8%), S&P 500 futures +50 points (+0.8%) and Nasdaq 100 futures +165 points (+0.7%). Canadian TSX futures gained while the Canadian index is on track for March losses as the ongoing Iran war keeps oil elevated above pre-conflict levels, lifting some energy and oilfield-service names. Notable stock moves: McCormick jumped on reports of advanced talks to combine with Unilever into a ~$60B food giant; Microsoft said it will invest >$1B in AI infrastructure in Thailand; PepGen and Phreesia slid on mixed clinical data and lowered revenue guidance respectively, and Service Properties Trust fell after a $500M share offering.

Analysis

Elevated geopolitical risk is amplifying oil-price convexity: pure-play E&P and lightly hedged independents (higher OXY-style beta) will materially outperform integrated majors on a sustained price shock, while refiners capture transitory windfalls via widened crack spreads. Shipping/insurance cost inflation and storage constraints are underappreciated transmission channels — they compress arbitrage flows and can keep physical differentials (e.g., inland Canadian heavy discounts) wider for quarters, pressuring TSX energy constituents relative to US peers.

AI-capex commitments by hyperscalers create a second-order bifurcation: platform owners with balance-sheet scale (MSFT-type) extract much of the value, while chassis and short-cycle hardware suppliers (SMCI/APP) see demand spikes but face rapid margin mean-reversion as tender cycles compress and competition intensifies. That dynamic creates asymmetric exposures where owning the platform and shorting select hardware names can monetize deployment vs. pricing risk over 6–12 months.

Biotech and small-cap equity issuance patterns are signaling near-term funding stress: negative trial readouts and dilutive follow-ons (SVC-like offerings) drive steep knee-jerk downdrafts but also create idiosyncratic entry points if upcoming catalysts are binary and de-risked. Overall, the market is pricing a near-term risk premium; the key trade is harvesting convexity while protecting against a diplomatic de-escalation that could erase the oil risk-premium inside 30–90 days.

Key Decisions for Investors

• Relative-energy pair (3-month): Long OXY calls vs short CVX calls (equal delta notional). Rationale: capture higher E&P leverage to oil while hedging integrated-hedge sensitivity. Position size: 1–2% NAV net premium; target 50–100% return on premium if oil rallies 15%+; max loss = premium paid.
• Refiner directional (6–12 week): Buy a bull call spread on MPC or VLO to play sustained crack spreads. Entry window: within next 10 trading days while volatility is elevated. Risk/reward: limited downside (premium) and target 30–50% return if refining margins remain elevated; trim 50% at +25% move.
• AI infra asymmetric (6–12 months): Buy MSFT (2–3% NAV) and hedge with a short-dated (3–6 month) put spread on SMCI for ~1:1 notional protection. Rationale: capture platform capture of AI spending while protecting against hardware price compression. Risk: hedged downside; reward: uncapped upside in MSFT with funded hedge reducing cost.
• Event-driven biotech hedge (up to 6 months): Purchase a PHR or PEPG put spread (limited-risk) ahead of the next clinical update or use a small short position sized to potential binary downside. Rationale: negative readouts are already priced in but remain high-probability — puts offer 2–4x payoffs vs defined loss. Close or reassess within 7 trading days post-catalyst.